Zhang Haidong and his delegation from Shandong First Medical University (Shandong Academy of Medical Sciences) visited and conducted research at Yinfeng Biotechnology Group
Release time:
2022-03-29
On March 29th, Zhang Haidong, Executive Vice President of the School of Clinical and Basic Medicine at Shandong First Medical University (Shandong Academy of Medical Sciences), Yue Yun, Deputy Secretary of the Party Committee, and Wang Dandan, Vice President, visited and conducted research at Yinfeng Biotechnology Group. Zhang Cheng, President of Yinfeng Biotechnology Group, Zhang Guirong, Assistant to the President and Director of Research and Development Department, and Hu Jinkun, Director of Human Resources Department, accompanied the delegation.
Zhang Haidong and his delegation visited the "Infinite Life Plan" science popularization museum and the "Life Continuation Plan" exhibition hall, gaining a detailed understanding of cell storage and application scenarios in 5G scenarios, the first human low-temperature preservation case in Asia, and the infinite possibilities of deep cryogenic medicine in tissue and organ transplantation and clinical applications.
After the visit, Zhang Cheng, President of Yinfeng Biotechnology Group, and Zhang Haidong gave a comprehensive introduction to Yinfeng Biotechnology Group's industrial layout, cutting-edge technology, research and development innovation, and achievement transformation in the biomedical field. The two sides had in-depth exchanges on the joint construction of talent training bases and scientific research achievement transformation cooperation between the hospital and enterprises. They jointly signed a practical teaching base agreement and held a licensing ceremony.
Yinfeng Biotechnology Group is a high-tech enterprise driven by "cell+gene" dual engine innovation, specializing in the research and development, medical transformation, and clinical research of biomedical technologies such as human cell, tissue, and organ storage, gene sequencing, cell application, deep and low-temperature medicine, and health management services. With 20 years of deep cultivation, Yinfeng Biotechnology has taken the lead in connecting the entire human life cycle health management service industry chain nationwide To become a leading domestic and internationally first-class human lifecycle health management service provider and contribute Yinfeng's strength to the development vision and serving "Healthy China".
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
